drugset / Trial / NCT00370110

Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers

NCT00370110

Phase 1/2 Completed 45 enrolled Forest Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

Itopride is a new compound that is already marketed in Japan and in some countries of Eastern Europe under the name of Ganaton. It is used to treat symptoms associated with gastroparesis. Due to inadequate gastric emptying, these patients often have symptoms of bloating, nausea and vomiting following ingestion of a meal. This is a randomized, parallel group, two dose double blind, placebo-controlled study evaluating the effects of itopride (100 mg and 200 mg three times daily) and placebo on gastric motor and sensory functions in healthy volunteers.

Timeline

Start
2005-08
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Itopride Small molecule 100 mg
Subject Itopride Small molecule 200 mg

Indications

No indication recorded.